Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

Context: Fibroblast growth factor 23 (FGF23) regulates phosphorus homeostasis and vitamin D metabolism. Circulating FGF23 levels are elevated in inherited and acquired hypophosphatemic disorders that can cause rickets or osteomalacia. Particularly increased concentrations of FGF23 are observed in pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Shimada, Takashi, Urakawa, Itaru, Isakova, Tamara, Yamazaki, Yuji, Epstein, Michael, Wesseling-Perry, Katherine, Wolf, Myles, Salusky, Isidro B., Jüppner, Harald
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Endocrine Society 2010
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840849/
https://ncbi.nlm.nih.gov/pubmed/19965919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-1603
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg